1 results match your criteria: "1 Florida Eye Microsurgical Institute[Affiliation]"
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial keratitis: a retrospective safety surveillance study.
J Ocul Pharmacol Ther
March 2015
1 Florida Eye Microsurgical Institute, Boynton Beach, Florida.
Purpose: The objective of this study was to collect and evaluate retrospective safety information about the use of besifloxacin ophthalmic suspension 0.6% for the treatment of bacterial keratitis.
Methods: This was a retrospective, postmarketing surveillance study conducted at 10 clinical centers in the United States.